{"id":70789,"date":"2026-05-12T11:08:40","date_gmt":"2026-05-12T11:08:40","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70789"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"ahk-cu","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/ahk-cu\/","title":{"rendered":"AHK-Cu"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 AHK-Cu\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>AHK-Cu<\/strong> \uff08\u30a2\u30e9\u30cb\u30eb\u2212\u30d2\u30b9\u30c1\u30b8\u30eb\u2212\u30ea\u30b7\u30f3\u9285\uff08II\uff09\u8907\u5408\u4f53\uff09\u306f\u5408\u6210\u9285\u7d50\u5408\u6027\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308a\u3001\u59c9\u59b9\u5206\u5b50\u3067\u3042\u308a\u3001 <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>. While GHK-Cu is the canonical skin and wound-healing copper peptide, AHK-Cu&#8217;s signal is concentrated in <strong>\u6bdb\u5305\u751f\u7269\u5b66<\/strong> \u2014 published preclinical work documents stimulation of dermal papilla cells, follicular enlargement, increased follicular vascularization, and prolongation of the anagen growth phase. Supplied in 20\u00a0mg and 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">110374-12-4\uff08AHK-Cu\uff09; 71567-06-1\uff08AHK\u904a\u96e2\u30da\u30d7\u30c1\u30c9\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub> \uff081:1\u9285\u8907\u5408\u4f53\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~417 Da\uff08\u9285\u8907\u5408\u4f53\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ala-His-Lys\uff08AHK\u30013\u30a2\u30df\u30ce\u9178\uff09\u304c1\u500b\u306eCu\u306b\u914d\u4f4d<sup>2+<\/sup> \u30a4\u30aa\u30f3\u306f\u3001His\u306e\u30a4\u30df\u30c0\u30be\u30fc\u30eb\u7a92\u7d20\u3001Ala\u306e\u30a2\u30df\u30ce\u672b\u7aef\u3001\u304a\u3088\u3073Ala\u3068His\u306e\u9593\u306e\u8131\u30d7\u30ed\u30c8\u30f3\u5316\u30da\u30d7\u30c1\u30c9\u7a92\u7d20\u3092\u4ecb\u3057\u3066<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u9285\u30da\u30d7\u30c1\u30c9\u8907\u5408\u4f53\uff08\u9752\u8272\u304b\u3089\u9752\u7d2b\u8272\u306e\u7c89\u672b\uff1b\u8272\u306f\u7d50\u5408\u3057\u305fCu\u306ed-d\u9077\u79fb\u306b\u7531\u6765\u3057\u307e\u3059<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f7f\u7528\u6642\u5728\u5eab\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u306b\u4fdd\u7ba1\u3002\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306b\u306f\u221220\u2103\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u671f\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34\u3002\u6c34\u306b\u53ef\u6eb6\uff1b\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u7d50\u5408\u3057\u305fCu\u306e\u7279\u5fb4\u7684\u306a\u9752\u8272\u3092\u4fdd\u6301\u3057\u307e\u3059\u3002<sup>2+<\/sup>.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>AHK-Cu\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h2>\n<p><strong>AHK-Cu<\/strong> \uff08\u30a2\u30e9\u30cb\u30eb-\u30d2\u30b9\u30c1\u30b8\u30eb-\u30ea\u30b8\u30f3\u9285(II)\u8907\u5408\u4f53\uff09\u306f\u30013\u3064\u306e\u30a2\u30df\u30ce\u9178Ala\u3001His\u3001Lys\u304b\u3089\u69cb\u6210\u3055\u308c\u3001\u5358\u4e00\u306eCu\u306b\u914d\u4f4d\u3057\u305f\u5408\u6210\u9285\u7d50\u5408\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3059<sup>2+<\/sup> \u30a4\u30aa\u30f3\u3002\u3053\u308c\u306f\u3001\u3088\u308a\u5e83\u7bc4\u306b\u7814\u7a76\u3055\u308c\u3066\u3044\u308b\u59c9\u59b9\u5206\u5b50\u3067\u3059 <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> \u2014 both belong to the &#8220;copper peptide&#8221; class, both share the same Cu-coordination architecture using a histidine residue, and both are studied in dermatological contexts. Where they diverge is in primary signal: GHK-Cu is the canonical peptide for skin remodelling, wound healing, and connective-tissue repair, while AHK-Cu&#8217;s most-cited applications are in <strong>\u6bdb\u5305\u751f\u7269\u5b66<\/strong>. The well-characterised molecular composition is C<sub>15<\/sub>H<sub>25<\/sub>CuN<sub>6<\/sub>O<sub>4<\/sub>, \u3001\u5206\u5b50\u91cf\u7d04417 Da\u3002Cu<sup>2+<\/sup> ion coordinates with the tripeptide via the imidazole nitrogen of histidine, the amino terminus of alanine, and the deprotonated peptide nitrogen between Ala and His \u2014 the same square-planar coordination geometry as in GHK-Cu. The bound copper gives both compounds their characteristic blue-to-violet colour in solid and dissolved form \u2014 users reconstituting AHK-Cu should expect a visibly blue working solution. AHK-Cu is supplied as a high-purity lyophilized copper-peptide complex for reconstitution with bacteriostatic water. The compound is <strong>\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u305b\u3093<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. For the sister skin-studies copper peptide, see our <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> \u88fd\u54c1\u30da\u30fc\u30b8\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 \u6bdb\u5305\u4e73\u982d\u7d30\u80de\u3078\u306e\u9285\u9001\u9054<\/h2>\n<p>AHK-Cu\u304c\u9285\u30da\u30d7\u30c1\u30c9\u306e\u4e2d\u3067\u6a5f\u69cb\u7684\u306b\u969b\u7acb\u3063\u3066\u3044\u308b\u306e\u306f\u3001\u305d\u306e <strong>\u6bdb\u4e73\u982d\u7d30\u80de\u306b\u304a\u3051\u308b\u512a\u5148\u7684\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054<\/strong> in the hair follicle \u2014 the mesenchymal cells at the base of each follicle that regulate hair-shaft production and cycle through the growth (anagen), regression (catagen), and rest (telogen) phases. Published studies has documented three principal mechanisms:<\/p>\n<ul>\n<li><strong>\u6bdb\u4e73\u982d\u7d30\u80de\u3078\u306e\u9285\u306e\u9001\u9054<\/strong> \u2014 Cu<sup>2+<\/sup> ion is the active payload of AHK-Cu (and of GHK-Cu in skin studies). The tripeptide is a vehicle that ferries the metal ion into target tissue, where copper participates in multiple enzyme cofactor roles including lysyl oxidase (collagen and elastin cross-linking) and superoxide dismutase (oxidative-stress buffering). At the hair follicle, dermal papilla cells take up copper from AHK-Cu and use it to support the follicular extracellular matrix and oxidative-stress management that anagen requires.<\/li>\n<li><strong>VEGF\u306e\u30a2\u30c3\u30d7\u30ec\u30ae\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u3068\u6bdb\u5305\u8840\u7ba1\u65b0\u751f<\/strong> \u2014 AHK-Cu\u306f\u6bdb\u4e73\u982d\u7d30\u80de\u306b\u304a\u3044\u3066\u8840\u7ba1\u5185\u76ae\u5897\u6b96\u56e0\u5b50\uff08VEGF\uff09\u306e\u767a\u73fe\u3092\u523a\u6fc0\u3057\u307e\u3059\u3002\u305d\u306e\u4e0b\u6d41\u52b9\u679c\u3068\u3057\u3066\u3001\u6bdb\u5305\u306e\u704c\u6d41\u304c\u5897\u52a0\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u6210\u9577\u671f\u306b\u6025\u901f\u306b\u5897\u6b96\u3059\u308b\u6bdb\u6bcd\u306e\u30b1\u30e9\u30c1\u30ce\u30b5\u30a4\u30c8\u306e\u4ee3\u8b1d\u9700\u8981\u3092\u652f\u3048\u308b\u305f\u3081\u306b\u3001\u6bdb\u5305\u57fa\u90e8\u3067\u306e\u65b0\u305f\u306a\u6bdb\u7d30\u8840\u7ba1\u306e\u6210\u9577\u3092\u5f15\u304d\u8d77\u3053\u3057\u307e\u3059\u3002\u3053\u306e\u704c\u6d41\u5897\u5f37\u30e1\u30ab\u30cb\u30ba\u30e0\u306f\u30df\u30ce\u30ad\u30b7\u30b8\u30eb\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u91cd\u306a\u308a\u307e\u3059\u304c\u3001\u6839\u672c\u7684\u306b\u7570\u306a\u308b\u7d4c\u8def\uff08ATP\u611f\u53d7\u6027\u30ab\u30ea\u30a6\u30e0\u30c1\u30e3\u30cd\u30eb\u306e\u8abf\u7bc0\u3067\u306f\u306a\u304f\u3001\u9285-\u30da\u30d7\u30c1\u30c9\u306b\u3088\u308b\u76f4\u63a5\u7684\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\uff09\u3092\u4ecb\u3057\u3066\u4f5c\u7528\u3057\u307e\u3059\u3002<\/li>\n<li><strong>\u6210\u9577\u671f\u306e\u5ef6\u9577\u3068\u6bdb\u5305\u80a5\u5927<\/strong> \u2014 In published rodent hair-cycle studies, AHK-Cu administration prolongs the duration of the anagen growth phase and increases overall follicular size. The combined effect is more hair-shaft production per follicle per cycle. The mechanism appears to be downstream of the copper-delivery and VEGF-upregulation steps \u2014 healthy, well-perfused follicles in a copper-replete environment sustain anagen for longer before transitioning to catagen.<\/li>\n<\/ul>\n<p>The mechanism is fundamentally different from the two FDA-approved hair-loss compounds: finasteride blocks 5-alpha-reductase to lower scalp DHT (hormonal mechanism); minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels (vascular mechanism). AHK-Cu provides direct mesenchymal-cell signalling and copper-cofactor delivery, working at a different point in follicular biology than either FDA-approved compound \u2014 which makes it a useful tool for dissecting follicular cell biology independent of androgen-axis or vasodilation-mediated mechanisms. Subcutaneous, topical, and intrafollicular injection routes are all documented in published studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>AHK-Cu is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Hair follicle biology studies<\/strong> \u2014 dermal papilla cell proliferation assays, follicular size measurement, hair-shaft diameter analysis, organ-cultured hair follicle studies; canonical copper-peptide compound for the hair-axis (Pyo et al., J Korean Med Sci 2007; Uno &amp; Kurata, J Investig Dermatol)<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 \u6210\u9577\u671f\uff0f\u9000\u884c\u671f\uff0f\u4f11\u6b62\u671f\u306e\u671f\u9593\u3001\u4f11\u6b62\u671f\u6bdb\u5305\u306b\u304a\u3051\u308b\u6210\u9577\u671f\u8a98\u5c0e\u3001\u78ba\u7acb\u3055\u308c\u305f\u6bdb\u8ef8\u6bd4\u8f03\u5316\u5408\u7269\u3068\u306e\u7528\u91cf\u53cd\u5fdc\u6bd4\u8f03<\/li>\n<li><strong>Follicular vascularization studies<\/strong> \u2014 VEGF\u767a\u73fe\u3001\u6bdb\u5305\u57fa\u90e8\u306e\u6bdb\u7d30\u8840\u7ba1\u5bc6\u5ea6\u3001\u6bdb\u5305\u5468\u56f2\u704c\u6d41\u6e2c\u5b9a<\/li>\n<li><strong>Comparative copper peptide studies<\/strong> \u2014 \uff5e\u3068\u306e\u76f4\u63a5\u6bd4\u8f03 <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> for dermatological studies; AHK-Cu favoured for hair-axis endpoints, GHK-Cu favoured for skin\/wound\/anti-aging endpoints<\/li>\n<li><strong>Topical and intradermal formulation studies<\/strong> \u2014 AHK-Cu is one of the more-studied copper peptides for topical and intradermal delivery; published studies investigates skin-penetration depth, follicular targeting via different vehicle formulations<\/li>\n<li><strong>\u8131\u6bdb\u30e1\u30ab\u30cb\u30ba\u30e0\u306e\u89e3\u660e<\/strong> \u2014 alongside finasteride (androgen-axis) and minoxidil (vascular axis), AHK-Cu provides a third orthogonal studies mechanism (mesenchymal-cell + copper-cofactor + VEGF axis); useful for mechanism-of-action studies designs<\/li>\n<li><strong>Collagen and elastin studies<\/strong> \u2014 copper&#8217;s role as cofactor for lysyl oxidase makes copper peptides relevant to studies on extracellular matrix crosslinking; AHK-Cu shares this mechanism with GHK-Cu at the broader level although hair-axis effects predominate.<\/li>\n<\/ul>\n<p>For broader context on where AHK-Cu fits within the copper-peptide and dermatological studies landscape, see <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> as the canonical skin-studies copper peptide, <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> for tissue-repair studies, and <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> for systemic recovery. Browse the full <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/a> \u5316\u5408\u7269\u9078\u629e\u306e\u305f\u3081\u306b\u3002 <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase stocks AHK-Cu in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 topical formulation and short-cycle protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Bulk packs vial, extended cycles, lowest per-mg cost, multi-cohort follicle studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized copper-peptide complex, 99%+ HPLC purity). Higher-mg vials are particularly useful for AHK-Cu because of the relatively large doses typical in topical-formulation studies compared with the microgram-range systemic peptides. Higher-mg vials require smaller reconstitution volumes per unit dose. <\/p>\n<h2>AHK-Cu\u3068GHK-Cu\u306e\u6bd4\u8f03<\/h2>\n<p>AHK-Cu\u3068 <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> are sister copper-binding tripeptides that share the same Cu-coordination chemistry but differ in the first amino-acid residue (Ala vs Gly). This minor structural difference produces qualitatively different signals: GHK-Cu dominates skin\/wound\/anti-aging studies while AHK-Cu&#8217;s strongest signal is in hair follicle biology. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">AHK-Cu<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">GHK-Cu<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30a2\u30df\u30ce\u9178\u6570<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3\u3064\u306e\u30a2\u30df\u30ce\u9178\uff08\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3\u3064\u306e\u30a2\u30df\u30ce\u9178\uff08\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-His-Lys<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Gly-His-Lys<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u9285\u914d\u4f4d<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> His\u304a\u3088\u3073N\u672b\u7aef\u3092\u4ecb\u3057\u3066<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1:1 Cu<sup>2+<\/sup> His\u304a\u3088\u3073N\u672b\u7aef\u3092\u4ecb\u3057\u3066<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Primary signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6bdb\u5305\u306e\u751f\u7269\u5b66\u3001\u6210\u9577\u671f\u5ef6\u9577<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u76ae\u819a\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u3001\u5275\u50b7\u6cbb\u7652\u3001\u30a2\u30f3\u30c1\u30a8\u30a4\u30b8\u30f3\u30b0<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u6a19\u7684\u7d30\u80de\u7a2e<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6bdb\u4e73\u982d\u7d30\u80de\uff08\u6bdb\u5305\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u771f\u76ae\u7dda\u7dad\u82bd\u7d30\u80de\u3001\u30b1\u30e9\u30c1\u30ce\u30b5\u30a4\u30c8\uff08\u76ae\u819a\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>VEGF\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5f37\u529b \u2014 \u6bdb\u5305\u8840\u7ba1\u65b0\u751f<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u4e2d\u7b49\u5ea6 \u2014 \u5275\u50b7\u5e8a\u306e\u8840\u7ba1\u65b0\u751f<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5185\u56e0\u6027\u5b58\u5728<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5408\u6210\uff08\u5185\u56e0\u6027\u306e\u6709\u610f\u306a\u30d7\u30fc\u30eb\u306a\u3057\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5185\u56e0\u6027\uff08\u8840\u6f3f\u4e2d\u6fc3\u5ea6\u306f\u52a0\u9f62\u3068\u3068\u3082\u306b\u4f4e\u4e0b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\uff5e10 mg \u5c40\u6240 \/ 1\uff5e5 mg \u76ae\u4e0b<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">1\uff5e5 mg \u5c40\u6240 \/ 0.5\uff5e2 mg \u76ae\u4e0b<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For hair-axis studies, AHK-Cu is the canonical first choice because of the dermal-papilla-cell selectivity and the documented anagen-prolongation signal. For skin remodelling, wound healing, and anti-aging studies, <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> is the canonical reference. Some studies designs use both in parallel arms to dissect copper-peptide effects that are shared (general Cu cofactor delivery) from effects that are sequence-specific (cell-type selectivity). <\/p>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u77ed\u671f\u4f7f\u7528\u306e\u30ef\u30fc\u30ad\u30f3\u30b0\u30b9\u30c8\u30c3\u30af\u306f\u3001\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u3092\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8 \u00b0C\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u672a\u958b\u5c01\u306e\u9577\u671f\u4fdd\u5b58\u306e\u5834\u5408\u306f\u3001\u221220 \u00b0C\u3067\u51cd\u7d50\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u4e7e\u71e5AHK-Cu\u306f\u51b7\u8535\u3067\u6700\u592724\u30f6\u6708\u3001\u221220 \u00b0C\u3067\u6700\u592736\u30f6\u6708\u5b89\u5b9a\u3067\u3059\u3002\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\u306e\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002Cu<sup>2+<\/sup> \u914d\u4f4d\u306f\u51cd\u7d50\u4e7e\u71e5\u5f62\u614b\u3067\u306f\u5b89\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002\u518d\u69cb\u6210\u5f8c\u306f\u3001\u5149\u3084\u9084\u5143\u5264\u3078\u306e\u9577\u6642\u9593\u306e\u66dd\u9732\u304c\u9285\u306e\u9178\u5316\u72b6\u614b\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u9759\u83cc\u6c34\u3092\u30da\u30d7\u30c1\u30c9\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u6ce8\u5165\u3057\u307e\u3059\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u300220 mg\u30d0\u30a4\u30a2\u30eb\u306e\u5834\u5408\u30012.0 mL\u306e\u9759\u83cc\u6c34\u306710 mg\/mL\u306e\u4f5c\u696d\u6fc3\u5ea6\u304c\u5f97\u3089\u308c\u307e\u3059 \u2014 0.1 mL\u30671 mg\u30010.5 mL\u30675 mg\u3092\u6295\u4e0e\u3057\u307e\u3059\u3002\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3066\u304f\u3060\u3055\u3044 \u2014 \u632f\u3068\u3046 <strong>\u3057\u307e\u305b\u3093<\/strong> \u305b\u305a\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30672\uff5e5\u5206\u9593\u5f85\u3061\u307e\u3059\u3002\u6b63\u3057\u304f\u518d\u69cb\u6210\u3055\u308c\u305f\u6eb6\u6db2\u306f\u900f\u660e\u3067\u3001\u7d50\u5408\u3057\u305fCu\u7279\u6709\u306e\u9752\u8272\u3092\u5448\u3059\u308b\u306f\u305a\u3067\u3059<sup>2+<\/sup>. \u3002\u6fc1\u308a\u3084\u6c88\u6bbf\u306f\u518d\u69cb\u6210\u306b\u554f\u984c\u304c\u3042\u308b\u3053\u3068\u3092\u793a\u3057\u307e\u3059\u3002\u5ec3\u68c4\u3057\u3066\u518d\u8a66\u884c\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u5b8c\u5168\u306b\u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> store refrigerated at 2\u20138\u00a0\u00b0C and use within 30 days for optimal stability. Do not freeze the reconstituted solution \u2014 freeze-thaw cycles degrade peptide integrity. Protect from direct light at all times. For topical formulation studies, AHK-Cu can be incorporated into a wide range of vehicles (creams, gels, serums) for follicle-studies delivery; published vehicle studies includes liposomal and microemulsion formulations for enhanced follicular penetration. <\/p>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is AHK-Cu used for in studies?<\/h3>\n<p>AHK-Cu is used in studies investigating hair follicle biology, dermal papilla cell proliferation, anagen phase prolongation, follicular vascularization, hair-shaft diameter, comparative copper-peptide pharmacology, topical and intradermal formulation studies, and mechanism-of-action dissection of hair-loss biology distinct from the androgen-axis (finasteride) and vascular (minoxidil) mechanisms. It is the canonical copper-peptide compound for the hair-axis. The pharmaceutical-grade AHK-Cu sold here is <strong>\u3057\u307e\u305b\u3093<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>AHK-Cu\u306fGHK-Cu\u3068\u3069\u3046\u9055\u3046\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u4e21\u8005\u306f\u9285\u7d50\u5408\u6027\u30c8\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308a\u3001\u540c\u3058Cu\u914d\u4f4d\u69cb\u9020\uff08His\u3092\u4ecb\u3057\u305f1:1\u306eCu<sup>2+<\/sup> binding). They differ in the first amino-acid residue \u2014 alanine in AHK-Cu, glycine in GHK-Cu \u2014 producing different cell-type selectivity in published studies. AHK-Cu&#8217;s strongest signal is in dermal papilla cells of the hair follicle; <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a>\u2018\u306e\u6700\u3082\u5f37\u3044\u30b7\u30b0\u30ca\u30eb\u306f\u76ae\u819a\u7dda\u7dad\u82bd\u7d30\u80de\u3068\u30b1\u30e9\u30c1\u30ce\u30b5\u30a4\u30c8\u306b\u3042\u308a\u307e\u3059\u3002\u3053\u306e2\u3064\u306f\u3001\u5171\u901a\u306e\u9285\u30da\u30d7\u30c1\u30c9\u52b9\u679c\u3068\u914d\u5217\u7279\u7570\u7684\u52b9\u679c\u3092\u5206\u96e2\u3059\u308b\u305f\u3081\u306b\u4e26\u884c\u3057\u3066\u7814\u7a76\u3055\u308c\u308b\u3053\u3068\u304c\u3088\u304f\u3042\u308a\u307e\u3059\u3002 <\/p>\n<h3>What is the typical AHK-Cu dose?<\/h3>\n<p>Published preclinical protocols typically use 1\u20135\u00a0mg per administration for subcutaneous delivery and 2\u201310\u00a0mg for topical formulation studies, given 1\u20133 times daily for 4\u201312 week cycles. A 20\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 10\u00a0mg\/mL \u2014 0.1\u00a0mL equals 1\u00a0mg, 0.5\u00a0mL equals 5\u00a0mg. <\/p>\n<h3>AHK-Cu\u306fFDA\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. AHK-Cu is not approved by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. Copper peptides have been incorporated into some cosmetic products under cosmetic-regulation frameworks, but AHK-Cu specifically has no therapeutic approval. <\/p>\n<h3>AHK-Cu\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u3079\u304d\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\uff1a\u77ed\u671f\u4f7f\u7528\u306e\u4f5c\u696d\u7528\u30b9\u30c8\u30c3\u30af\u306f2\uff5e8 \u00b0C\u3067\u51b7\u8535\u3001\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306f\u221220 \u00b0C\u3067\u51b7\u51cd\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u6eb6\u89e3\u6db2\uff1a2\uff5e8 \u00b0C\u3067\u51b7\u8535\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u6eb6\u89e3\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u30da\u30d7\u30c1\u30c9\u3092\u5206\u89e3\u3057\u3001\u9285\u306e\u914d\u4f4d\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u9285\u306e\u9178\u5316\u72b6\u614b\u3092\u4fdd\u3064\u305f\u3081\u3001\u5e38\u306b\u76f4\u5c04\u5149\u3092\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>AHK-Cu\u3092\u3069\u306e\u3088\u3046\u306b\u6eb6\u89e3\u3057\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u4e0a\u8a18\u306e\u518d\u6eb6\u89e3\u624b\u9806\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3092\u30d0\u30a4\u30a2\u30eb\u306e\u5185\u58c1\u306b\u6cbf\u3063\u3066\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u5f53\u3066\u306a\u3044\u3088\u3046\u306b\uff09\u52a0\u3048\u3001\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30672\uff5e5\u5206\u9593\u7f6e\u304d\u307e\u3059\u3002 <strong>\u3057\u307e\u305b\u3093<\/strong> \u30d0\u30a4\u30a2\u30eb\u3092\u632f\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u6b63\u3057\u304f\u518d\u6eb6\u89e3\u3055\u308c\u305f\u6eb6\u6db2\u306f\u3001\u7d50\u5408\u3057\u305fCu\u306e\u7279\u5fb4\u7684\u306a\u9752\u8272\u3092\u5448\u3057\u3001\u6f84\u3093\u3067\u3044\u307e\u3059<sup>2+<\/sup> \u2015 \u8272\u305d\u306e\u3082\u306e\u304c\u518d\u6eb6\u89e3\u304c\u6210\u529f\u3057\u3001\u9285\u914d\u4f4d\u304c\u640d\u306a\u308f\u308c\u3066\u3044\u306a\u3044\u3053\u3068\u3092\u78ba\u8a8d\u3057\u307e\u3059\u300220 mg\u30d0\u30a4\u30a2\u30eb\u306b2.0 mL\u306e\u5e0c\u91c8\u6db2\u3092\u4f7f\u7528\u3057\u305f\u5834\u5408\u3001\u4f5c\u696d\u6fc3\u5ea6\u306f10 mg\/mL\u3067\u3059\u3002 <\/p>\n<h3>MedsBase\u3067\u306f\u3069\u306e\u5bb9\u91cf\u306e\u30ec\u30bf\u30eb\u30c8\u30eb\u30c1\u30c9\u3092\u53d6\u308a\u63c3\u3048\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase carries AHK-Cu in 20\u00a0mg and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>AHK-Cu\u304c\u9752\u8272\u3092\u3057\u3066\u3044\u308b\u306e\u306f\u306a\u305c\u3067\u3059\u304b\uff1f<\/h3>\n<p>AHK-Cu\uff08\u304a\u3088\u3073GHK-Cu\uff09\u306e\u7279\u5fb4\u7684\u306a\u9752\u304b\u3089\u7d2b\u306e\u8272\u306f\u3001\u7d50\u5408\u3057\u305fCu\u306ed-d\u96fb\u5b50\u9077\u79fb\u306b\u7531\u6765\u3057\u3001<sup>2+<\/sup> \u30d2\u30b9\u30c1\u30b8\u30f3\u6b8b\u57fa\u3068\u30da\u30d7\u30c1\u30c9\u4e3b\u9396\u304c\u5f62\u6210\u3059\u308b\u5e73\u9762\u56db\u914d\u4f4d\u74b0\u5883\u306b\u304a\u3044\u3066\u751f\u3058\u307e\u3059\u3002\u3053\u306e\u8272\u306f\u9285\u914d\u4f4d\u304c\u6210\u529f\u3057\u3066\u3044\u308b\u3053\u3068\u306e\u6709\u7528\u306a\u5b9a\u6027\u7684\u6307\u6a19\u3067\u3042\u308a\u3001\u9069\u5207\u306b\u518d\u6eb6\u89e3\u3055\u308c\u305f\u9752\u8272\u6eb6\u6db2\u306f\u640d\u306a\u308f\u308c\u3066\u3044\u306a\u3044Cu\u7d50\u5408\u3092\u78ba\u8a8d\u3067\u304d\u3001<sup>2+<\/sup> \u4e00\u65b9\u3001\u7121\u8272\u307e\u305f\u306f\u8584\u3044\u6eb6\u6db2\u306f\u9285\u306e\u6b20\u5931\u3084\u5206\u89e3\u3092\u793a\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u5c0f\u30da\u30d7\u30c1\u30c9\u306e\u4e2d\u3067\u3082\u30e6\u30cb\u30fc\u30af\u3067\u3001\u307b\u3068\u3093\u3069\u306e\u5408\u6210\u30da\u30d7\u30c1\u30c9\u306f\u518d\u6eb6\u89e3\u3059\u308b\u3068\u7121\u8272\u306e\u6eb6\u6db2\u3092\u751f\u3058\u307e\u3059\u3002 <\/p>\n<h3>AHK-Cu\u306f\u30d5\u30a3\u30ca\u30b9\u30c6\u30ea\u30c9\u3084\u30df\u30ce\u30ad\u30b7\u30b8\u30eb\u3068\u3069\u306e\u3088\u3046\u306b\u6bd4\u8f03\u3055\u308c\u307e\u3059\u304b\uff1f<\/h3>\n<p>The three target hair-loss biology through completely different mechanisms. Finasteride blocks 5-alpha-reductase to lower scalp dihydrotestosterone (DHT) levels \u2014 an androgen-axis mechanism. Minoxidil opens ATP-sensitive potassium channels to vasodilate follicular vessels \u2014 a vascular mechanism. AHK-Cu provides direct copper-cofactor delivery and VEGF-mediated follicular vascularization at the dermal papilla cell level \u2014 a mesenchymal-cell mechanism. The three mechanisms are orthogonal, which makes AHK-Cu a useful tool for studying follicular biology independent of androgen-axis or vasodilation-mediated effects. <\/p>\n<h3>Does AHK-Cu cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a notably clean safety profile at typical doses, with the main on-target effect being follicular stimulation. Off-target findings can include local injection-site irritation and (with prolonged high-dose topical exposure) modest cutaneous discolouration from copper deposition \u2014 both reversible with discontinuation. Systemic adverse effects from topical applications are rare due to limited transcutaneous absorption. <\/p>\n<h3>AHK-Cu\u306e\u534a\u6e1b\u671f\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>In preclinical studies, AHK-Cu has a relatively short plasma half-life (~1\u20132 hours) following subcutaneous administration. The short half-life is offset by retention of bound copper in target tissues \u2014 even after plasma clearance, the copper delivered to dermal papilla cells continues to support follicular biology through its enzyme-cofactor roles. Topical formulations provide sustained local exposure that is more relevant for hair-axis studies than the systemic plasma profile. <\/p>\n<h3>Can AHK-Cu and GHK-Cu be stacked in studies?<\/h3>\n<p>Yes. The two copper peptides target different cell types (dermal papilla for AHK-Cu, dermal fibroblasts for GHK-Cu) and address different studies domains (hair vs skin), so co-administration is not pharmacologically redundant. Study protocols studying combined skin-and-hair endpoints \u2014 for example, comprehensive dermatological remodelling studies \u2014 sometimes use both arms. <\/p>\n<h3>How long does AHK-Cu take to show effects in preclinical studies?<\/h3>\n<p>Acute effects on dermal papilla cell VEGF expression are detectable within 24\u201372 hours in cell-culture studies. Follicular size and anagen-prolongation effects in rodent hair-cycle models typically become statistically significant after 4\u20138 weeks of regular treatment and continue to accrue through 12\u201316 weeks \u2014 matching the natural hair-cycle timeframe. <\/p>\n<h3>AHK-Cu\u3092\u6d77\u5916\u914d\u9001\u3067\u3054\u6ce8\u6587\u3044\u305f\u3060\u3051\u307e\u3059\u304b\uff1f<\/h3>\n<p>Yes. MedsBase ships AHK-Cu worldwide from our dedicated peptide shipping network. Peptide-only orders qualify for our standalone peptide shipping service. All orders ship in temperature-controlled packaging with full tracking and are covered by our <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\">\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Hair, Skin, and Tissue-Regeneration Studies<\/h2>\n<ul>\n<li><a href=\"\/ja\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Sister copper-binding tripeptide \u2014 canonical skin remodelling and wound-healing compound<\/li>\n<li><a href=\"\/ja\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-regeneration and recovery<\/li>\n<li><a href=\"\/ja\/tb-500\/\"><strong>TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff09<\/strong><\/a> \u2014 Systemic healing fragment \u2014 tissue and vascular recovery<\/li>\n<li><a href=\"\/ja\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/ja\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Nootropic heptapeptide \u2014 CNS compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the copper-peptide studies landscape<\/strong><\/p>\n<p style=\"margin: 0;\">\u3059\u3079\u3066\u3092\u95b2\u89a7 <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\"><strong>\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/strong><\/a>, \u3001\u95a2\u9023\u3059\u308b\u76ae\u819a\u79d1\u5b66\u304a\u3088\u3073\u7d44\u7e54\u518d\u751f\u5316\u5408\u7269\u3092\u542b\u3080 <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu<\/a> (sister copper peptide for skin studies), <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> \uff08\u7d44\u7e54\u518d\u751f\uff09\u3001 <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> \u304a\u3088\u3073.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u30a2\u30e9\u30cb\u30eb-\u30d2\u30b9\u30c1\u30b8\u30eb-\u30ea\u30b7\u30f3\u9285\uff08II\uff09\u30c8\u30ea\u30da\u30d7\u30c1\u30c9<br \/>\n\u2705 GHK-Cu\u306e\u59c9\u59b9\u5206\u5b50<br \/>\n\u2705 Hair follicle biology compound<br \/>\n\u2705 \u6bdb\u4e73\u982d\u7d30\u80de\u306e\u523a\u6fc0\u3001\u6210\u9577\u671f\u5ef6\u9577<br \/>\n\u2705 \u30d5\u30a3\u30ca\u30b9\u30c6\u30ea\u30c9\uff0f\u30df\u30ce\u30ad\u30b7\u30b8\u30eb\u3068\u306f\u7570\u306a\u308b\u4f5c\u7528\u6a5f\u5e8f<\/p>\n<p><strong>AHK-Cu<\/strong> \u5408\u6210\u9285\u30da\u30d7\u30c1\u30c9\u8907\u5408\u4f53\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70940,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6290,5441],"class_list":["post-70789","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-ahk-cu","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/70789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=70789"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70940"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=70789"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=70789"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=70789"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=70789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}